A detailed history of Roberts Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Roberts Capital Advisors, LLC holds 5,732 shares of ABBV stock, worth $945,722. This represents 0.98% of its overall portfolio holdings.

Number of Shares
5,732
Previous 5,732 -0.0%
Holding current value
$945,722
Previous $983,000 15.06%
% of portfolio
0.98%
Previous 0.95%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $66,005 - $75,207
-413 Reduced 6.72%
5,732 $1.04 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $660,157 - $835,289
6,145 New
6,145 $832,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Roberts Capital Advisors, LLC Portfolio

Follow Roberts Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roberts Capital Advisors, LLC with notifications on news.